Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Season
Unlock with PBS Passport
55:29
Norman Ornstein; Mouaz Moustafa; Charlie Warzel; Edward Berger
Unlock with PBS Passport
55:46
Errol Morris; Jacob Soboroff; Omer Bartov; Paul Krugman
Unlock with PBS Passport
55:36
Narges Mohammadi; Mark Esper; Jia Tolentino
Unlock with PBS Passport
55:47
Tom Fletcher; Martin Baron; Kris Brown
Unlock with PBS Passport
55:47
Dmytro Kuleba; Mediha Ibrahim Alhamad and Hasan Oswald; Jennifer Granholm
Unlock with PBS Passport
55:47
Stephen Rapp; Angela Patton; Natalie Rae; Eric Schmidt
Unlock with PBS Passport
55:47
Philippe Lazzarini; Payal Kapadia; Mohamad Hafez
Unlock with PBS Passport
55:31
Sheikh Abdulrahman Al Thani; FM Barth Eide; FM Jaishankar; Alex Gibney; Alexis Bloom; M. Gessen
Unlock with PBS Passport
55:31
Clarissa Ward; Kaja Kallas; Elbridge Colby; Noah Bookbinder and Gregg Nunziata
Unlock with PBS Passport
55:45
Rami Jarrah; Geir Pedersen; Jon Finer; Abby Edaburn; Jacob Tice
Unlock with PBS Passport
55:47
Gabrielius Landsbergis; Thierry Arnaud; Hayat Tahrir Al-Sham; Daniel Bogado and Barry Hirshorn
Unlock with PBS Passport
55:46
Mosab Abu Toha; Demi Moore; Ronan Farrow